Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977 Feb;39(2):665-70.
doi: 10.1002/1097-0142(197702)39:2<665::aid-cncr2820390244>3.0.co;2-b.

Rhabdomyosarcoma: response with chemotherapy prior to radiation in patients with gross residual disease

M Tefft, C H Fernandez, T E Moon
Clinical Trial

Rhabdomyosarcoma: response with chemotherapy prior to radiation in patients with gross residual disease

M Tefft et al. Cancer. 1977 Feb.

Abstract

One hundred and ten Group III patients enrolled in the IRS Study have been reviewed. Of these, 39 are fully and 56 are partially evaluable. Combining the data for both groups 77/95 (81%) have shown complete or partial response/no measurable disease and this has been maintained in 53/95 (56%). No patient received premature RT for local progression during the time of pre-radiation chemotherapy. However, 15/95 patients have shown local recurrence or direct extension to neighboring tissues; 13/15 could be reviewed. Only 3/13 have recurred at a time related to the delay in starting radiation. Overall survival for Group III patients is 72%-85% (Regimen F and Regimen E respectively).

PubMed Disclaimer

Publication types